# Micophenolate Mofetil Versus Azathioprine in Myocarditis

> **NCT05237323** · PHASE3 · COMPLETED · sponsor: **I.M. Sechenov First Moscow State Medical University** · enrollment: 50 (actual)

## Conditions studied

- Lymphocytic Myocarditis (Disorder)
- Heart Failure
- Dilated Cardiomyopathy
- Cardiomyopathies
- Sudden Cardiac Death

## Interventions

- **DRUG:** mycophenolate mofetil 2 g per day
- **DRUG:** azathioprine of 150 [75; 150] mg per day

## Key facts

- **NCT ID:** NCT05237323
- **Lead sponsor:** I.M. Sechenov First Moscow State Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2025-07-10
- **Final completion:** 2025-07-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05237323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05237323, "Micophenolate Mofetil Versus Azathioprine in Myocarditis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05237323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*